All Federal Contract Awards
Help

Definitive Contract 75N91023C00059

Award Date 9/30/23
Potential Completion Date 3/29/25
Potential Value $3.5M
Funding Federal Agency
National Institutes of Health
Contracting Federal Agency
National Cancer Institute
Awardee
Satio Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,500,000.00 Firm Fixed Price Definitive Contract to Satio Inc., a small business manufacturer, to develop a very low cost, remotely controllable, disposable microneedle transdermal drug delivery device under the ARPA-H MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE TOPIC 02 program. This contract was set aside for total small business and is expected to be completed by March 29, 2025.

Generated 8/21/24, 6:23 PM

A Portfolio Platform of GovExec © 2025